Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 30:9:45.
doi: 10.4103/abr.abr_27_20. eCollection 2020.

Evaluating the Effect of Utrogestan on Idiopathic Intrauterine Growth Retardation

Belgheis Mohammadi  1 , Marzieh Matinfar  2 , Fatemeh Drees  3 , Sheida Shabanian  1
Affiliations

Evaluating the Effect of Utrogestan on Idiopathic Intrauterine Growth Retardation

Belgheis Mohammadi et al. Adv Biomed Res. .

Abstract

Background: Intrauterine growth factor (IUGR) is one of the most important causes of neonatal mortality. The aim of this study was to evaluate the therapeutic effect of utrogestan on the treatment of IUGR and its complications.

Materials and methods: In this clinical trial, 66 pregnant women with idiopathic IUGR embryos were enrolled. Patients in the intervention group, in addition to receiving routine treatment of control group (high-protein diet, resting), took utrogestan capsules (100 mg) twice daily. The primary and secondary outcomes of the disease were recorded in a checklist. Data were analyzed using SPSS 18 using an independent t-test, Chi-square test, and Fisher's exact test.

Results: In the intervention group, mean neonatal weight (P = 0.003), mean neonatal Apgar score (P = 0.001), and mean gestational age at birth (P = 0.001) were significantly higher than those in the control group. There was no neonatal death in the intervention group, whereas in the control group, four cases of neonatal death were observed (P = 0.03). In the majority of subjects in the intervention group, resistance index, and pulsatility index of the umbilical artery decreased (P = 0.002). The difference in abdominal circumference and gestational age in the intervention group decreased (P = 0.01). In the intervention group, the diastolic flow of the umbilical artery increased (P = 0.002).

Conclusion: Utrogestan was effective as an inexpensive and effective way to treat IUGR and improve pregnancy outcomes.

Keywords: Fetal growth retardation; placenta; utrogestan.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Consort 2010 flow diagram for this study
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction – Part 1. J Matern Fetal Neonatal Med. 2016;29(24):3977–87. - PubMed
    1. Said, Joanne M. The role of proteoglycans in contributing to placental thrombosis and fetal growth restriction. J Pregnancy. 2011;2011:1–5. - PMC - PubMed
    1. Pereira L, Petitt M, Fong A, Tsuge M, Tabata T, Fang-Hoover J, et al. Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis. 2014;209(10):1573–84. - PMC - PubMed
    1. Gaudineau A. [Prevalence, risk factors, maternal and fetal morbidity and mortality of intrauterine growth restriction and small-for-gestational age] J Gynecol Obst Bio R. 2013;42(8):895–910. - PubMed
    1. Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clin Med Insights Pediatr. 2016;10:CMPed–S40070. - PMC - PubMed